RPM International is set to report its Q3 2026 earnings on October 6, with analysts forecasting earnings per share of $1.95 and revenue of $2.22 billion, both higher than the previous year. Despite a slight recent dip in the EPS estimate, the report is important for investors to assess the company's financial health and future outlook. Morgan Stanley recently lowered its price target for RPM, signaling cautious optimism. Investors will watch the earnings results and management commentary for insights into business conditions and growth strategies.
RPM International's upcoming Q3 2026 earnings report provides context for investors as they evaluate its financial outlook. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Oct 02, 2026 01:21 WIB: of 38 priced US Basic Materials stocks, 8 rose and 29 fell today. Notable prices include Rio Tinto (ADR) at USD 92.51 with a 1-day change of -1.76% and a typical hold time on Pluang of 6 days, Ecolab Inc. at USD 271.11 with a 1-day change of -1.34% and Pluang order activity showing 89% sell and 11% buy, and Johnson Controls International PLC at USD 150.60 with a 1-day change of +1.31% and a typical hold time of 65 days.
Foghorn Therapeutics saw its price target cut from $12 to $5 after it and Eli Lilly decided not to advance key cancer drug programs. The companies will not continue development of FHD-909 or a selective SMARCA2 degrader, ending their collaboration. F...
Jefferies increased its price target for Regeneron to $930, citing an expanded partnership with Sanofi to develop four new long-acting antibodies targeting inflammatory pathways. Sanofi will pay Regeneron $1 billion upfront, with potential milestone ...
McCormick & Company reported fiscal Q3 results with adjusted EPS of $0.86, surpassing estimates of $0.76, and revenue of $2.02 billion, up 17.4% from last year. Growth was driven by the McCormick de Mexico acquisition, pricing actions, and favorable ...
Aehr Test Systems is set to report Q3 earnings of $0.11 per share and revenue around $27 million, marking a 1,000% increase in earnings year-over-year. The company projects fiscal 2027 revenue growth between 160% and 200%, reaching $130-$150 million,...
HSBC upgraded Target's stock rating from Hold to Buy and set a new price target of $190, about 21.4% above the current share price of $156.45. This upgrade follows Target's strong recent quarterly earnings, reporting $26.54 billion in revenue and $8....
